UHS
50
4
ES
12
3
MDLZ
28
2
HPE
48
2
HIG
48
5
AA
27
5
DGX
28
4
CA
19
6
RCL
74
5
PEG
53
7
ADBE
50
3
NKE
36
2
LUV
45
3
ZBH
69
15
JWN
72
9
CCL
68
6
WU
26
2
MCD
52
3
NEM
30
2
TGNA
48
5
UHS
50
4
ES
12
3
MDLZ
28
2
HPE
48
2
HIG
48
5
AA
27
5
DGX
28
4
CA
19
6
RCL
74
5
PEG
53
7
ADBE
50
3
NKE
36
2
LUV
45
3
ZBH
69
15
JWN
72
9
CCL
68
6
WU
26
2
MCD
52
3
NEM
30
2
TGNA
48
5
Financhill
Back

Excelerate Energy 10K Form

Sell
19

EE
Excelerate Energy

Last Price:
$29.72
Seasonality Move:
-13.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EE News And Ratings

See the #1 stock for the next 7 days that we like better than EE

EE Financial Statistics

Sales & Book Value

Annual Sales: $1.2B
Cash Flow: $28.3M
Price / Cash Flow: 7.95
Annual Sales: $20.34
Price / Book: 1.44

Profitability

EPS (TTM): 0.99000
Net Income (TTM): $25.7M
Gross Margin: $298.1M
Return on Equity: 1.4%
Return on Assets: 0.89%

Excelerate Energy Earnings Forecast

Key Excelerate Energy Financial Ratios

  • The Gross Profit Margin over the past 28 years for EE is 25.72%.
  • The Selling, General & Administrative Expenses for EE have been equal to 7.55% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 220.29% of Operating Income.
  • The Net Earning history of EE is 2.62% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 17 years.

Excelerate Energy Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Oil, Gas & Consumable Fuels
Sector: Energy
Current Symbol: EE
CUSIP: 283677
Website: excelerateenergy.com

Debt

Debt-to-Equity Ratio: 1.03
Current Ratio: 4.12
Quick Ratio: 4.03

Price-to-Earnings

Trailing P/E Ratio: 26.82
Forward P/E Ratio: 23.49

EE Technical Analysis vs Fundamental Analysis

Sell
19
Excelerate Energy (EE) is a Sell

Is Excelerate Energy a Buy or a Sell?

  • Excelerate Energy stock is rated a Sell
    The current Excelerate Energy [EE] share price is $29.77. The Score for EE is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.